Epstein-Barr/JJ
viral/JJ
latency/NN
is/VBZ
disrupted/VBN
by/IN
the/DT
immediate-early/JJ
BRLF1/NN
protein/NN
through/IN
a/DT
cell-specific/JJ
mechanism/NN
./.

Epstein-Barr/JJ
virus/NN
(/(
EBV/NN
)/)
,/,
the/DT
causative/JJ
agent/NN
of/IN
infectious/JJ
mononucleosis/NN
,/,
is/VBZ
a/DT
human/JJ
herpesvirus/NN
associated/VBN
with/IN
epithelial/JJ
cell/NN
malignancies/NNS
(/(
nasopharyngeal/JJ
carcinoma/NN
)/)
as/RB
well/RB
as/IN
B-cell/NN
malignancies/NNS
./.
=====
Understanding/VBG
how/WRB
viral/JJ
latency/NN
is/VBZ
disrupted/VBN
is/VBZ
a/DT
central/JJ
issue/NN
in/IN
herpesvirus/JJ
biology/NN
./.
=====
Epithelial/JJ
cells/NNS
are/VBP
the/DT
major/JJ
site/NN
of/IN
lytic/JJ
EBV/NN
replication/NN
within/IN
the/DT
human/JJ
host/NN
,/,
and/CC
viral/JJ
reactivation/NN
occurs/VBZ
in/IN
EBV-associated/JJ
nasopharyngeal/JJ
carcinomas/NNS
./.
=====
It/PRP
is/VBZ
known/VBN
that/IN
expression/NN
of/IN
a/DT
single/JJ
viral/JJ
immediate-early/JJ
protein/NN
,/,
BZLF1/NN
,/,
is/VBZ
sufficient/JJ
to/TO
initiate/VB
the/DT
switch/NN
from/IN
latent/JJ
to/TO
lytic/JJ
infection/NN
in/IN
B/NN
cells/NNS
./.
=====
Cellular/JJ
regulation/NN
of/IN
BZLF1/NN
transcription/NN
is/VBZ
therefore/RB
thought/VBN
to/TO
play/VB
a/DT
key/JJ
role/NN
in/IN
regulating/VBG
the/DT
stringency/NN
of/IN
viral/JJ
latency/NN
./.
=====
Here/RB
we/PRP
show/VBP
that/IN
,/,
unexpectedly/RB
,/,
expression/NN
of/IN
another/DT
viral/JJ
immediate-early/JJ
protein/NN
,/,
BRLF1/NN
,/,
can/MD
disrupt/VB
viral/JJ
latency/NN
in/IN
an/DT
epithelial/JJ
cell-specific/JJ
fashion/NN
./.
=====
Therefore/RB
,/,
the/DT
mechanisms/NNS
leading/VBG
to/TO
disruption/NN
of/IN
EBV/NN
latency/NN
appear/VBP
to/TO
be/VB
cell-type/NN
specific/JJ
./.